Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vijay Kevlani

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Drug Delivery and Translational Research|August 12, 2024
Ferrous ascorbate non-effervescent floating mini-caplets as an oral iron supplementShital Trivedi, Vijay Kevlani, Shreeraj Shah
Drug Delivery and Translational Research|November 11, 2023
A novel Posaconazole oral formulation using spray dried solid dispersion technology: in-vitro and in-vivo studyKaushika Patel, Vijay Kevlani, Shreeraj Shah
Assay and Drug Development Technologies|August 25, 2025
Neuroprotective Potential of Saroglitazar Against Cerebral Ischemia/Reperfusion Injury in Sprague Dawley Rats: Targeting HMGB-1/NF-κB PathwayPrachi Mistry, Sanjiv Prajapati, Paridhi Vadher, et al.
Drug Delivery and Translational Research|February 23, 2023
Development and evaluation of novel krill oil-based clomiphene microemulsion as a therapeutic strategy for PCOS treatmentDarshita Panchal, Tosha Pandya, Vijay Kevlani, et al.
Assay and Drug Development Technologies|July 8, 2025
Neuroprotective Potential of Saroglitazar Against Cerebral Ischemia/Reperfusion Injury in Sprague-Dawley Rats: Targeting HMGB-1/NF-κB PathwayPrachi Mistry, Sanjiv Prajapati, Paridhi Vadher, et al.
AAPS Pharmscitech|August 21, 2024
Antipsoriatic Effect of Silymarin NLCs Based Gel: In Vitro and In Vivo ActivityFaijmahmad Momin, Vijay Kevlani, Shruti Rawal, et al.
Molecular Diversity|July 1, 2025
Synthesis, molecular docking, molecular dynamic simulation and biological evaluation of novel 3,4-dihydropyridine derivatives as potent antituberculosis agentsRiya Khandelwal, Mahesh Vasava, Vijay Kevlani, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Drug Delivery and Translational Research|August 12, 2024
Ferrous ascorbate non-effervescent floating mini-caplets as an oral iron supplementShital Trivedi, Vijay Kevlani, Shreeraj Shah
Drug Delivery and Translational Research|November 11, 2023
A novel Posaconazole oral formulation using spray dried solid dispersion technology: in-vitro and in-vivo studyKaushika Patel, Vijay Kevlani, Shreeraj Shah
Assay and Drug Development Technologies|August 25, 2025
Neuroprotective Potential of Saroglitazar Against Cerebral Ischemia/Reperfusion Injury in Sprague Dawley Rats: Targeting HMGB-1/NF-κB PathwayPrachi Mistry, Sanjiv Prajapati, Paridhi Vadher, et al.
Drug Delivery and Translational Research|February 23, 2023
Development and evaluation of novel krill oil-based clomiphene microemulsion as a therapeutic strategy for PCOS treatmentDarshita Panchal, Tosha Pandya, Vijay Kevlani, et al.
Assay and Drug Development Technologies|July 8, 2025
Neuroprotective Potential of Saroglitazar Against Cerebral Ischemia/Reperfusion Injury in Sprague-Dawley Rats: Targeting HMGB-1/NF-κB PathwayPrachi Mistry, Sanjiv Prajapati, Paridhi Vadher, et al.
AAPS Pharmscitech|August 21, 2024
Antipsoriatic Effect of Silymarin NLCs Based Gel: In Vitro and In Vivo ActivityFaijmahmad Momin, Vijay Kevlani, Shruti Rawal, et al.
Molecular Diversity|July 1, 2025
Synthesis, molecular docking, molecular dynamic simulation and biological evaluation of novel 3,4-dihydropyridine derivatives as potent antituberculosis agentsRiya Khandelwal, Mahesh Vasava, Vijay Kevlani, et al.
Pageof 1